Enact Pharma Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

Enact Pharma General Information

Description

Developer of cancer and neurological drugs based in Salisbury, United Kingdom. The company discovers and develops cancer and neurological treatment and drugs that includes NQO2, Pure Z-Tamoxifen, and Nerve Regeneration.

Contact Information

Formerly Known As
Enact Pharma PLC, Enzacta Group, Kymed GB, HALLCO 282
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • First Floor
  • 5 Fleet Place
  • London EC4M 7RD
  • England, United Kingdom
Primary Industry
Drug Delivery
Acquirer
Corporate Office
  • First Floor
  • 5 Fleet Place
  • London EC4M 7RD
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enact Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enact Pharma‘s full profile, request access.

Request a free trial

Enact Pharma Patents

Enact Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0303362-D0 Tissue regeneration Inactive 13-Feb-2003
GB-0102951-D0 Plant toxin Inactive 06-Feb-2001
GB-0029767-D0 Antimicrobial compositions Inactive 06-Dec-2000

Enact Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enact Pharma Acquisitions (1)

Enact Pharma’s most recent deal was a Merger of Equals with Enzacta Group. The deal was made on 01-Apr-2000.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Enzacta Group 01-Apr-2000 Merger of Equals Drug Delivery
To view Enact Pharma’s complete acquisitions history, request access »

Enact Pharma FAQs

  • When was Enact Pharma founded?

    Enact Pharma was founded in 1999.

  • Where is Enact Pharma headquartered?

    Enact Pharma is headquartered in London, United Kingdom.

  • What is the size of Enact Pharma?

    Enact Pharma has 7 total employees.

  • What industry is Enact Pharma in?

    Enact Pharma’s primary industry is Drug Delivery.

  • Is Enact Pharma a private or public company?

    Enact Pharma is a Private company.

  • What is the current valuation of Enact Pharma?

    The current valuation of Enact Pharma is .

  • What is Enact Pharma’s current revenue?

    The current revenue for Enact Pharma is .

  • When was Enact Pharma acquired?

    Enact Pharma was acquired on 15-Jun-2003.

  • Who acquired Enact Pharma?

    Enact Pharma was acquired by Protherics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process